Citation 84480

CHEN,JJ: CHANG,YL: TENG,CM: CHEN,IS:. (2000). ANTI-PLATELET AGGREGATION ALKALOIDS AND LIGNANS FROM HERNANDIA NYMPHAEIFOLIA.. 66(3)

Citation Details

Title	ANTI-PLATELET AGGREGATION ALKALOIDS AND LIGNANS FROM HERNANDIA NYMPHAEIFOLIA.
Authors	CHEN,JJ: CHANG,YL: TENG,CM: CHEN,IS:
Year	2000
Volume	66
Issue	3

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (1)

Hernandia nymphaeifolia (HERNANDIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BULBOCAPNINE,N-(N-METHYL-CARBAMOYL)-O-METHYL:	None
2	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
5	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PODORHIZOL,5'-METHOXY: (-):	None
6	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PODORHIZOL,5'-METHOXY: (-):	INACTIVE
7	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PODORHIZOL,5'-METHOXY: (-):	WEAK ACTIVITY
8	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PODORHIZOL,5'-METHOXY: (-):	WEAK ACTIVITY
9	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PODORHIZOL,5'-METHOXY: (-):	WEAK ACTIVITY
10	Not specified	ISOLATION AND IDENTIFICATION OF	ATHEROLINERETICULINE,(+):YATEIN,(-):HERNANDALINETHALICARPINE,(+):LAUROTETANINEHERNANDONINEHERNANDALINE,DEHYDRO:HERNAGINE,7-OXO:HERNANGERINE,7-OXO:VATEAMINE,2'-BETA-N-OXIDE: (+):PODOPHYLLOTOXIN,DEOXY: (-):MAGNOLIN,EPI: (+):ASCHANTIN,EPI: (+):YANGAMBIN,EPI: (+):HERNONE,(-):OVIGERIDIMERINE	None
11	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LAUROTETANINE	INACTIVE
12	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LAUROTETANINE	ACTIVE
13	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LAUROTETANINE	ACTIVE
14	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LAUROTETANINE	ACTIVE
15	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNAGINE,7-OXO:	INACTIVE
16	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNAGINE,7-OXO:	ACTIVE
17	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNAGINE,7-OXO:	ACTIVE
18	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNAGINE,7-OXO:	ACTIVE
19	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VATEAMINE,2'-BETA-N-OXIDE: (+):	ACTIVE
20	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VATEAMINE,2'-BETA-N-OXIDE: (+):	ACTIVE
21	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VATEAMINE,2'-BETA-N-OXIDE: (+):	ACTIVE
22	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VATEAMINE,2'-BETA-N-OXIDE: (+):	ACTIVE
23	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	YATEIN,(-):	INACTIVE
24	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	YATEIN,(-):	ACTIVE
25	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	YATEIN,(-):	ACTIVE
26	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	YATEIN,(-):	ACTIVE
27	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RETICULINE,(+):	INACTIVE
28	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RETICULINE,(+):	ACTIVE
29	ANTISICKLING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RETICULINE,(+):	ACTIVE
30	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RETICULINE,(+):	WEAK ACTIVITY
31	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNONE,(-):	INACTIVE
32	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNONE,(-):	WEAK ACTIVITY
33	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNONE,(-):	WEAK ACTIVITY
34	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNONE,(-):	ACTIVE
35	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THALICARPINE,(+):	ACTIVE
36	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THALICARPINE,(+):	ACTIVE
37	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THALICARPINE,(+):	ACTIVE
38	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THALICARPINE,(+):	ACTIVE
39	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASCHANTIN,EPI: (+):	INACTIVE
40	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASCHANTIN,EPI: (+):	ACTIVE
41	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASCHANTIN,EPI: (+):	ACTIVE
42	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASCHANTIN,EPI: (+):	ACTIVE
43	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MAGNOLIN,EPI: (+):	INACTIVE
44	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MAGNOLIN,EPI: (+):	ACTIVE
45	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MAGNOLIN,EPI: (+):	ACTIVE
46	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MAGNOLIN,EPI: (+):	ACTIVE
47	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	YANGAMBIN,EPI: (+):	INACTIVE
48	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	YANGAMBIN,EPI: (+):	WEAK ACTIVITY
49	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	YANGAMBIN,EPI: (+):	WEAK ACTIVITY
50	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	YANGAMBIN,EPI: (+):	ACTIVE
51	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PODOPHYLLOTOXIN,DEOXY: (-):	INACTIVE
52	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PODOPHYLLOTOXIN,DEOXY: (-):	ACTIVE
53	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PODOPHYLLOTOXIN,DEOXY: (-):	ACTIVE
54	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PODOPHYLLOTOXIN,DEOXY: (-):	ACTIVE
55	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNANDALINE	ACTIVE
56	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNANDALINE	ACTIVE
57	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNANDALINE	ACTIVE
58	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNANDALINE	ACTIVE
59	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNANDONINE	INACTIVE
60	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNANDONINE	ACTIVE
61	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNANDONINE	EQUIVOCAL
62	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNANDONINE	INACTIVE
63	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNANGERINE,7-OXO:	INACTIVE
64	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNANGERINE,7-OXO:	WEAK ACTIVITY
65	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNANGERINE,7-OXO:	WEAK ACTIVITY
66	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNANGERINE,7-OXO:	INACTIVE
67	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATHEROLINE	INACTIVE
68	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATHEROLINE	INACTIVE
69	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATHEROLINE	INACTIVE
70	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ATHEROLINE	WEAK ACTIVITY
71	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNANDALINE,DEHYDRO:	INACTIVE
72	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNANDALINE,DEHYDRO:	WEAK ACTIVITY
73	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNANDALINE,DEHYDRO:	INACTIVE
74	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERNANDALINE,DEHYDRO:	ACTIVE
75	ANTISICKLING ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OVIGERIDIMERINE	INACTIVE
76	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OVIGERIDIMERINE	INACTIVE
77	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OVIGERIDIMERINE	INACTIVE
78	PLATELET AGGREGATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OVIGERIDIMERINE	INACTIVE
79	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SITOSTERONE,BETA:	None
80	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STIGMASTA-4-22-DIEN-3-ONE	None
81	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STIGMAST-5-EN-7-ONE,3-BETA-HYDROXY:	None
82	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STIGMASTA-5-22-DIEN-7-ONE,3-BETA-HYDROXY:	None
83	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STIGMAST-4-EN-3-ONE,6-ALPHA-HYDROXY:	None
84	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STIGMASTA-4-22-DIEN-3-ONE,6-ALPHA-HYDROXY:	None

Citation 84480

Citation Details

Summary

Organisms and Their Experiments (1)

Hernandia nymphaeifolia (HERNANDIACEAE)

Show SPARQL Queries (1)

Query 1